To determine the mechanism by which glioblastoma cells acquire resistance to RTK inhibitors, U87 cells overexpressing EGFR were treated with increasing concentrations of gefitinib and resistant clones were isolated, expanded and subject to RNA sequencing (RNAseq). Here, EGFR is linked to glioblastoma.